Your session is about to expire
← Back to Search
Vaginal Seeding for Cesarean Section Babies (MOTHER SEED Trial)
MOTHER SEED Trial Summary
This trial tests if swabbing babies born by C-section with secretions from mom's vagina is safe and can modify their early-life microbiome.
MOTHER SEED Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MOTHER SEED Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently taking antibiotics or drugs that suppress my immune system.I or someone I live with had COVID-19 in the last 4 weeks.I do not have a fever or any signs of infection in my genital area today.I have had a fever of 100.4°F or higher in the last 3 days.I have been diagnosed with diabetes.I have had pelvic inflammatory disease.I am a healthy woman aged 18-40, can consent, and will follow the study rules.I am scheduled for a C-section due to an infection that prevents vaginal delivery.I have had hepatitis B, C, or HIV.I had symptoms like pain during urination, itching, or discharge suggesting an infection on the day I gave birth.I don't have any health issues that could affect my safety or participation in the study.
- Group 1: Intervention Group
- Group 2: Control Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment involve geriatric participants?
"Individuals between the ages of 18 and 40 are eligible to be enrolled in this medical trial."
Are there still vacancies for individuals to take part in this experiment?
"Affirmative. The clinicaltrials.gov database indicates that this research project is currently recruiting participants, starting with the original posting date of November 9th 2022 and most recently updated on November 16th 2022. 40 people are needed from one particular medical facility to partake in this trial."
How extensive is the participant base for this clinical experiment?
"Affirmative, the information posted on clinicaltrials.gov suggests that this medical trial is currently accepting participants. It was first listed on November 9th 2022 and amended most recently on November 16th. In total, 40 patients are required to be registered from a single site."
Is enrollment available for this clinical investigation?
"Participants of this trial must be no older than 40 years and possess a minimum age requirement of 18. This research protocol intends to enrol forty individuals."
Share this study with friends
Copy Link
Messenger